Is Journey Medical Corporation (DERM) a Buy, Sell, or Hold?
NASDAQ : DERM
Journey Medical Corporation — Institutional Ownership
$6.43 USD
-$0.1 (-1.53%)
- Volume
- 389.81K
- Average Volume
- 262.51K
- Market Capitalization
- $176.96M
- P/E Ratio
- -17.11
- Dividend Yield
- 0.00%
- Price Target
- $11.75
- Year High
- $9.56
- Year Low
- $4.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.72
Institutional Ownership Summary
Institutional Ownership %
12.47%
Investors Holding
19
change: -53.0 | last: 72
Increased Positions
12
change: -33.0 | last: 45
Reduced Positions
7
change: -11.0 | last: 18
New Positions
8
change: -5.0 | last: 13
Sold Positions
61
change: 44.0 | last: 17
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: 0.0 | last: 0
Total Invested
24.11M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-15 | Wasatch Advisors LP | 2.86M | 13.30% |
| 2026-04-30 | Vanguard Capital Management | 1.21M | 5.65% |
| 2026-04-06 | Wasatch Advisors LP | 2.13M | 10.00% |
| 2025-08-14 | WASATCH ADVISORS LP | 1.15M | 6.70% |
| 2025-05-15 | TANG CAPITAL MANAGEMENT, LLC | 1.85M | 8.00% |
| 2025-05-13 | WASATCH ADVISORS LP | 930.6K | 5.40% |
| 2022-08-17 | Fortress Biotech, Inc. | 10.01M | 56.90% |
| 2022-02-11 | Bryant R. Riley | 939.7K | 5.60% |
| 2022-02-11 | B. Riley Securities, Inc. | 864.7K | 5.20% |
| 2022-02-11 | B. Riley Financial, Inc. | 864.7K | 5.20% |
DERM Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.71 | 24.5M | $188.88M | $24.09M | $25.4M | $190.19M |
| 2024-12-31 | $3.91 | 20.43M | $79.89M | $20.3M | $25.7M | $85.29M |
| 2023-12-31 | $5.76 | 18.23M | $105.02M | $27.44M | $17.73M | $95.31M |
| 2022-12-31 | $1.92 | 17.53M | $33.66M | $32M | $22.96M | $24.62M |
| 2021-12-31 | $5.38 | 17.32M | $93.16M | $49.08M | $910K | $44.99M |
| 2020-12-31 | $9.50 | 16.66M | $158.27M | $8.25M | $9.92M | $159.94M |
| 2019-12-31 | $9.50 | 16.66M | $158.27M | $4.8M | $5.3M | $158.77M |
| 2018-12-31 | $9.50 | 42M | $399.03M | $104.98M | $313.79M | $607.84M |
| 2017-12-31 | $9.50 | 40.56M | $385.34M | $295.92M | $279.39M | $368.8M |
| 2016-12-31 | $9.50 | 50.73M | $481.96M | $41.79M | -$ | $440.17M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4.69 | 27.31M | $128.06M | $27.22M | $25.47M | $126.31M |
| 2025-12-31 | $7.71 | 24.5M | $188.88M | $24.09M | $25.4M | $190.19M |
| 2025-09-30 | $7.12 | 24.96M | $177.71M | $24.95M | $25.3M | $178.06M |
| 2025-06-30 | $7.18 | 23.29M | $167.23M | $20.29M | $25.28M | $172.21M |
| 2025-03-31 | $5.90 | 22.61M | $133.41M | $21.07M | $25.17M | $137.5M |
| 2024-12-31 | $3.91 | 22.15M | $86.62M | $20.3M | $25.7M | $92.02M |
| 2024-09-30 | $5.65 | 20.54M | $116.04M | $22.46M | $19.82M | $113.4M |
| 2024-06-30 | $5.37 | 19.99M | $107.37M | $23.91M | $22.81M | $106.26M |
| 2024-03-31 | $3.31 | 19.76M | $65.4M | $24.06M | $17.77M | $59.11M |
| 2023-12-31 | $5.76 | 19.32M | $111.31M | $27.44M | $17.73M | $101.6M |
| 2023-09-30 | $2.74 | 18.42M | $50.46M | $24.75M | $131K | $25.84M |
| 2023-06-30 | $1.59 | 18.01M | $28.63M | $8.23M | $10.1M | $30.49M |